# Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema

> **NCT02002403** · PHASE2 · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 34 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Danazol

## Key facts

- **NCT ID:** NCT02002403
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02002403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02002403, "Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02002403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*